NCT02213068 - Belatacept 3 Month Post Transplant Conversion Study | Biotech Hunter

Enrollment

Participants

Timeline

Start Date

July 31, 2014

Primary Completion Date

September 30, 2020

Study Completion Date

September 30, 2020

Conditions

Transplant; Failure, KidneyEBV

Interventions

DRUG

belatacept

Please reference Arm description for belatacept + MPA and Arm description for Arm belatacept + Low-Dose Tac for details on this intervention

DRUG

Tacrolimus

Please see Arm Descriptions for both Standard of Care Arm Tacrolimus + MPA standard treatment regimen and belatacept + Low-Dose Tac for details on this intervention

DRUG

MPA

Please see Arm Descriptions for both Standard of Care Arm Tacrolimus + MPA standard treatment regimen and belatacept + MPA for details on this intervention

Trial Locations (1)

60611

Northwestern University, The Comprehensive Transplant Center, Chicago